Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 2/20 | 0.57 |
| ▸ | MDM4 | O15151 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.54 |
| ▸ | CASP3 | P42574 | 2/20 | 0.53 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29768618 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL29400804 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL29762010 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL800035 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL800305 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL29362132 | 1.00 | FDFT1 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| Sulfur Dioxide SCHEMBL29187399 | 0.98 | FDFT1 (0.56) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL30437543 | 0.93 | MDM2 (0.57) | FDFT1MDM4TP53MDM2CASP3 | |
| SCHEMBL9062110 | 0.92 | MDM4 (0.58) | MDM4TP53MDM2CASP3TLR2 | |
| SCHEMBL9062116 | 0.92 | MDM4 (0.58) | MDM4TP53MDM2CASP3TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242572-A1 | a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | JIANGXI NORMAL UNIVERSITY (CN) | 2023-08-03 | — | — | US | claimed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| CN-110312730-B | Cytotoxins and conjugates, uses thereof and methods of preparation | 四川科伦博泰生物医药股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-114920851-B | Aβ1-42 antigen and use thereof for detecting Aβ1-42 concentration in Alzheimer's patient | 福建亿彤生物科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| CN-118047737-A | Preparation method of amide compound | 湖北师范大学 | 2024-05-17 | — | — | CN | disclosed |
| US-20240148664-A1 | LIPID AND COMPOSITION | SOGO PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| CN-114957438-B | Human Abeta 1-42 epitope polypeptide for detecting Alzheimer disease and preparation method thereof | 福建亿彤生物科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240076311-A1 | METHOD FOR SYNTHESIZING PEPTIDE THIOESTERS AND HEAD-TO-TAIL AMIDE CYCLIC PEPTIDE THEREOF | JIANGSU GENSCRIPT BIOTECH CO., LTD. (CN) | 2024-03-07 | — | — | US | disclosed |
| WO-2024043313-A1 | REVERSIBLE THERMOCHROMIC COMPOSITION, MICROENCAPSULATED PIGMENT USING SAID REVERSIBLE THERMOCHROMIC COMPOSITION, WRITING TOOL, AND TOY | 三菱ケミカル株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-20060275213-A1 | Tumor targeting agents and uses thereof | KARYON OY (FI) | 2006-12-07 | — | — | US | disclosed |
| CN-1720258-A | Tumor targeting agents and uses thereof | KARYON OY (FI) | 2006-01-11 | — | — | CN | disclosed |
| CN-1706865-A | Branched polyglycol-amino acid oligopeptide and its active derivative and medicinal composition | BEIJING JIANKAI SCI TECH CO LT (CN) | 2005-12-14 | — | — | CN | disclosed |
| EP-1549669-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | Karyon OY (FI) | 2005-07-06 | — | — | EP | disclosed |
| EP-0986384-A4 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIV PITTSBURGH (US) | 2004-09-15 | — | — | EP | disclosed |
| WO-2004031221-A9 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004031221-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-04-15 | — | — | WO | disclosed |
| US-6310095-B1 | INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE | UNIVERSITY OF PITTSBURGH | 2001-10-30 | — | — | US | disclosed |
| EP-0986384-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998050029-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148664-A1 | LIPID AND COMPOSITION | PLIN3, PLIN1, FABP1 | FDFT1 322/4885MDM4 2121/4885TP53 1707/4885 |
| US-20240076311-A1 | METHOD FOR SYNTHESIZING PEPTIDE THIOESTERS AND HEAD-TO-TAIL AMIDE CYCLIC PEPTIDE THEREOF | VIP, CETP, PITHD1 | FDFT1 3288/4885MDM4 3923/4885TP53 954/4885 |
| US-20230242572-A1 | a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | ACSL1, ACSL4, WEE1 | FDFT1 472/4885MDM4 3883/4885TP53 3299/4885 |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | FDFT1 609/4885MDM4 3559/4885TP53 2654/4885 |
| US-20060275213-A1 | Tumor targeting agents and uses thereof | CCL2, CCL5, SCTR | FDFT1 4387/4885MDM4 901/4885TP53 46/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | FDFT1 609/4885MDM4 3559/4885TP53 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.